Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality
Open Access
- 26 February 2015
- journal article
- Published by American Society of Hematology in Blood
- Vol. 125 (9) , 1470-1476
Abstract
Key Points: Platelet transfusions are frequently administered to hospitalized patients with platelet consumptive/destructive disorders such as TTP, HIT, and ITP. Platelet transfusions are associated with higher odds of arterial thrombosis and mortality among TTP and HIT patients.Keywords
This publication has 47 references indexed in Scilit:
- How I treat heparin-induced thrombocytopeniaBlood, 2012
- Treatment and Prevention of Heparin-Induced ThrombocytopeniaChest, 2012
- Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic strokeJournal of Thrombosis and Haemostasis, 2011
- Platelet Biology and Implications for Antiplatelet Therapy in Atherothrombotic DiseaseClinical and Applied Thrombosis/Hemostasis, 2010
- Outcomes after platelet transfusion in patients with heparin‐induced thrombocytopeniaJournal of Thrombosis and Haemostasis, 2010
- Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpuraAmerican Journal of Hematology, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Comparison of Self-Report, Hospital Discharge Codes, and Adjudication of Cardiovascular Events in the Women's Health InitiativeAmerican Journal of Epidemiology, 2004
- Laboratory abnormalities in thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 1998
- Thrombotic Thrombocytopenic Purpura: Experience with Whole Blood Exchange TransfusionSeminars in Thrombosis and Hemostasis, 1981